ID    AVR/I/SSAP480
ET    Non-clinical
PN    Phe-P-113
PL    12 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Synthetic peptide
TX    Not available
VL    Experimentally validated
XX
TO    VRSA02
IC    MIC = 64 microG/ML
TH    Phe-P-113 exhibited low toxicity and hemolytic activity. It caused minimal cell death and hemolysis, indicating a favorable safety profile compared to other peptides with bulkier hydrophobic side chains.
XR    PubMed: 32605123
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: Not available
XX
SQ    SEQUENCE  
      Ac- A K R  Phe Phe G  Y K R K F  Phe -NH2 
//

